Published October 2, 2020
| Version v1
Journal article
Open
Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination
Creators
- 1. University of Chicago
Description
Cancer vaccines have been actively pursued to bolster antitumor immunity. Here, we designed nanoscale metal-organic frameworks (nMOFs) as locally activable immunotherapeutics to release danger-associated molecular patterns (DAMPs) and tumor antigens and deliver pathogen-associated molecular patterns (PAMPs) for in situ personalized cancer vaccination. When activated by x-rays, nMOFs effectively generate reactive oxygen species to release DAMPs and tumor antigens while delivering CpG oligodeoxynucleotides as PAMPs to facilitate the maturation of antigen-presenting cells. Together, DAMPs, tumor antigens, and PAMPs expand cytotoxic T cells in tumor-draining lymph nodes to reinvigorate the adaptive immune system for local tumor regression. When treated in combination with an immune checkpoint inhibitor, the local therapeutic effects of nMOF-based vaccines were extended to distant tumors via attenuating T cell exhaustion. Our work demonstrates the potential of nMOFs as x-ray-activable in situ cancer vaccines to awaken the host's innate and adaptive immune systems for systemic antitumor immunity.
Data availability
All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.Files
sciadv.abb5223.pdf
Files
(3.6 MB)
| Name | Size | Download all |
|---|---|---|
|
Supplementary materials md5:8682090dda8e0e55b949365c76bfb5be |
2.5 MB | Preview Download |
|
Article md5:554dc67e4373a8bac9770f1fc7b05d56 |
1.0 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1126/sciadv.abb5223
- Other
- oai:uchicago.tind.io:10963
Funding
- National Institutes of Health
- U01–CA198989
- National Institutes of Health
- 1R01CA253655
- U.S. Department of Defense
- PC170934P2